Simultaneous Occurrence Of Chronic-Phase Chronic Myeloid Leukemia And Lymphoproliferative Neoplasms.

来源 :The 35th World Congress of the International Society of Hema | 被引量 : 0次 | 上传用户：webgame1209327274

【摘要】

：

Concurrent manifestation of two myeloid and lymphoid neoplasms in one patient is rare.Due to its rarety,the origin of both diseases is still a matter of debate,whether the two malignancies arose from

【作者】

：

Anastasia Athanasiadou Georgios Papaioannou Niki Stavroyianni Aliki Tsompanakou Chrysanthi Vadikoliou Leonidas Sakkas Maria Gaitatzi Tasoula Touloumenidou Zografia Lazarou Achilleas Anagnostopoulos

【机构】

：

G Papanicolaou Hospital

【出处】

：

The 35th World Congress of the International Society of Hema

【发表日期】

：

2014年5期

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

Concurrent manifestation of two myeloid and lymphoid neoplasms in one patient is rare.Due to its rarety,the origin of both diseases is still a matter of debate,whether the two malignancies arose from the same clone or from independent clones.Chronic Myeloid Leukemia (CML) Follicular Lymphoma (FL) and Chronic Lymphocytic Leukemia (CLL) are distinct hematological neoplasms.

其他文献

Thalassemia intermedia caused by interaction of beta-globin EKLF binding site mutation with Hb E and

Although thalassemia intermedia patients have mild anemia and do not require regular blood transfusion,they may still suffer from a number of serious clinical complications.We have characterized the m

会议

Increased Incidence Of Trisomy 8 In Aplastic Anemia Patients Combined With Behcet'S

Background Behcets disease (BD) is a disease of unknown cause which is clinically characterized by recurrent oral and genital ulcers,uveitis,polyarthritis,gastrointestinal involvement,and vasculitis.T

会议

Immunosuppressive treatment combined with cord blood infusion for12 patients in severe aplastic anem

Aim We report a single-center experience in treating 12 patients with severe aplastic anemia (SAA) who received immunosuppressive treatment combined with unrelated cord blood infusion.Methods The medi

会议

IL-1 receptor accessory protein as a surface marker for leukemia stem cells is related to clinical p

Chronic myeloid leukemia (CML) is a clonal disease from hematopoietic stem cells.Surviving leukemia stem cells (LSCs) and progenitor cells are a potential source for CML relapse and progression.Recent

会议

Second-generation tyrosine kinase inhibitors combined with allogeneic hematopoietic stem cell transp

Blast crisis (BC)is highly refractory to therapy and has a poor prognosis.To determine the efficacy of TKIs-Ⅱ com bined with allogeneic hematopoietic stem cell transplantation (allo-HSCT) in CML BC,we

会议

Wnt5a enhances the response of CML cells to Imatinib Mesylate through JNK activation and gama-cateni

Imatinib Mesylate is widely used for the treatment of chronic myelogenous leukaemia (CML),and its effects on CML cells are influenced by several signalling proteins.The research is aimed at determinin

会议

The Study of Molecular Mechanism on Peptide Extract from Scorpion Venom in Inhibiting Chronic Myeloc

Objective To investigate the peptide extracts from scorpion venom (PESVs) producing an effect on BCR/ABL fusion gene and P210,ras,bcl-xl,JAK1,p53,Bax expression in CML-NOD/SCID mice,to research the me

会议

Relation and regulatory mechanism between the concentration of Imatinib in bone marrow cells and the

Objective To determine the relationship of Imatinib (IM) concentration in bone marrow and its therapeutic response in patients with chronic myelogenous leukemia inChina.To explore the underlying mecha

会议

Case Report Extensive Bone Marrow Necrosis (BMN) in A Chronic myeloid leukemia Patient was resolved

Extensive bone marrow necrosis (BMN) has been described as a rare complication of chronic myeloid leukemia (CML).The prognoses of the patients with BMN were poor.There is no effective treatment for BM

会议

Inhibition of 32Dp210 Cells Harboring T315I Mutation by a Novel Derivative of Emodin Correlates with

Purpose The clinical outcome of chronic myeloid leukemia (CML) patients has been changed dramatically due to the development of imatinib (IM).However,the emergence of IM resistance,commonly associated

会议

Simultaneous Occurrence Of Chronic-Phase Chronic Myeloid Leukemia And Lymphoproliferative Neoplasms.

与本文相关的学术论文